Ocugen (NASDAQ:OCGN) Azioni, Quote.MetaTitle.unusual-options

Ocugen

Ocugen Inc

Absci

ADC Therapeutics

Akebia Therapeutics

Altimmune

Aura Biosciences

Autolus Therapeutics plc - American Depositary Shares

Autolus Therapeutics

Bicycle Therapeutics plc - American Depositary Shares

Bicycle Therapeutics

Benitec Biopharma

Cullinan Therapeutics, Inc. - Common Stock

Cullinan Therapeutics

Cellectis S.A. - American Depositary Shares

Cellectis

DBV Technologies S.A. - American Depositary Shares

DBV Technologies

Bright Minds Biosciences Inc. - common stock

Bright Minds Biosciences

Design Therapeutics

Immuneering Corporation - Class A Common Stock

Immuneering

Ironwood Pharmaceuticals, Inc. - Class A Common Stock

Ironwood Pharmaceuticals

Jade Biosciences

Kamada

Lineage Cell Therapeutics, Inc. Common Stock

Lineage Cell Therapeutics

Lyell Immunopharma

NovaBridge Biosciences - American Depositary Shares

NovaBridge Biosciences

Neurogene

ProKidney Corp. - Class A Ordinary Shares

ProKidney

Rocket Pharmaceuticals, Inc. - Common Stock

Rocket Pharmaceuticals

Tectonic Therapeutic, Inc. - Common Stock

Tectonic Therapeutic

XOMA Royalty

Ocugen (OCGN) Previsione

Notizie

Utili

Quote.Nav.option-chain

Valutazioni degli analisti

Insider trading

Vendite allo scoperto

Commerci governativi

Rapporto azionario

Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").

Comments

Ocugen Opzioni Inusuali

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO